Search

Your search keyword '"Nakamura, Michio"' showing total 852 results

Search Constraints

Start Over You searched for: Author "Nakamura, Michio" Remove constraint Author: "Nakamura, Michio"
852 results on '"Nakamura, Michio"'

Search Results

6. Excess mortality in COVID-19-affected solid organ transplant recipients across the pandemic

7. Guidance on mucositis assessment from the MASCC Mucositis Study Group and ISOO: an international Delphi study

10. Feasibility of edoxaban for asymptomatic cancer-associated thrombosis in Japanese patients with gastrointestinal cancer: ExCAVE study

12. A multicenter, prospective, phase II trial of second‐line aflibercept plus FOLFIRI in patients with metastatic colorectal cancer refractory to an anti‐EGFR antibody: HGCSG1801.

13. Outcome of surgical parathyroidectomy for tertiary hyperparathyroidism in kidney transplant recipients: tertiary hyperparathyroidism should not be ignored, for the sake of precious allografts.

19. The Influence of Age on the Outcomes of Traumatic Brain Injury: Findings from a Japanese Nationwide Survey (J-ASPECT Study-Traumatic Brain Injury)

20. Chemotherapy in cancer patients undergoing haemodialysis: a nationwide study in Japan

22. The risk of weekend biopsy: Impact of specimen source and fixation status on HER2 assessment in the treatment of advanced gastric cancer (The HER_WEEKEND study)

23. Development and nationwide validation of kidney graft injury markers using urinary exosomes and microvesicles (complete English translation of the Japanese version)

25. HGCSG1801: A multicenter, prospective, phase II trial of second-line FOLFIRI plus aflibercept in patients with metastatic colorectal cancer (mCRC) refractory to anti-EGFR antibodies.

28. Long-term Changes in Age-Sex Groups of the Captors and Developmental Stages of the Prey in the Red Colobus Hunting Behavior by the Chimpanzees of Mahale, Tanzania

29. Correlation of UGT1A1 Gene Polymorphisms or Prior Irinotecan Treatment and Treatment Outcomes of Nanoliposomal-Irinotecan plus 5-Fluorouracil/Leucovorin for Pancreatic Ductal Adenocarcinoma : A Multicenter, Retrospective Cohort Study (HGCSG2101)

31. Correlation of UGT1A1 Gene Polymorphisms or Prior Irinotecan Treatment and Treatment Outcomes of Nanoliposomal-Irinotecan plus 5-Fluorouracil/Leucovorin for Pancreatic Ductal Adenocarcinoma: A Multicenter, Retrospective Cohort Study (HGCSG2101)

39. Development and nation-wide validation of kidney graft injury markers using urinary exosomes and microvesicles (complete English translation of the Japanese version)

40. Study protocol for HGCSG1801: A multicenter, prospective, phase II trial of second-line FOLFIRI plus aflibercept in patients with metastatic colorectal cancer refractory to anti-EGFR antibodies

42. An Autopsy Case of Rapidly Aggravated Clostridium perfringens Septicemia with Colorectal Cancer

47. MO2-2 HGCSG2101: A real-world analysis of nanoliposomal irinotecan plus 5-FU/LV in pancreatic ductal adenocarcinoma

48. O1-6 REVIVE study: An observational study in chemotherapy (CTx) after nivolumab (NIVO) for advanced gastric cancer (AGC)

50. Phase II Study of Continued Trastuzumab Plus Irinotecan in Patients with HER2-positive Gastric Cancer Previously Treated with Trastuzumab (HGCSG 1201)

Catalog

Books, media, physical & digital resources